Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 165,196 shares at $27.03 ($4.5M) on 2025-01-16, disclosed to the SEC on 2025-01-21.
Scheduled sale ($4.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.96 | 40,553 | $1.1M | 24.5% |
| 2 | $26.96 | 40,553 | $1.1M | 24.5% |
| 3 | $27.03 | 25,915 | $700K | 15.7% |
| 4 | $27.03 | 25,915 | $700K | 15.7% |
| 5 | $27.04 | 1,692 | $46K | 1.0% |
| 6 | $27.22 | 7,753 |
| $211K |
| 4.7% |
| 7 | $27.22 | 7,753 | $211K | 4.7% |
| 8 | $27.28 | 6,981 | $190K | 4.3% |
| 9 | $27.28 | 6,981 | $190K | 4.3% |
| 10 | $27.40 | 1,100 | $30K | 0.7% |
| Total | $27.04 avg | 165,196 | $4.5M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |